JOURNAL ARTICLE
VALIDATION STUDIES
Add like
Add dislike
Add to saved papers

Validity and reliability study for the NEI-VFO-39 scale in chronic ophthalmic diseases--Turkish version.

PURPOSE: To test the reliability and validity of National Eye Institute Visual Function Questionnaire (NEI-VFQ-39) in patients with glaucoma, cataract, diabetic retinopathy and age-related macular degeneration.

METHODS: The study was carried out on 210 patients and 51 control subjects. The data were collected by using a data collection form and NEI-VFQ-39. Statistical analyses were performed with spss for Windows version 15.0.

RESULTS: Cronbach's alpha coefficient was 0.96 for the whole group. Cronbach's alpha coefficient was between 0.97 and 0.56 for the subscales. There was a strong relationship (r > 0.80) in 12.8% with dual correlation in NEI-VFQ-39 global scales and subscales and their correlations in all participant groups. There was a statistically significant difference for the NEI-VFn global and subscale scores between the control and patient groups except for general health and ocular pain.

CONCLUSIONS: We found that the NEI-VFQ-39 was a valid and reliable scale to determine the quality of life in Turkish patients with chronic ophthalmic disease.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app